Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-151236

ACCELERON PHARMA INC · XLRN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jean George
Director
Period of report
Nov 16, 2016
Accepted (ET)
Nov 18, 2016 · 4:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280600

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3,F4,F5Nov 16, 2016S32,929$41.39D420,576ISee footnotes
Common StockF6,F7,F8,F4,F5Nov 17, 2016S41,112$39.13D379,464ISee footnotes
Common StockF9,F4,F5Nov 17, 2016S379,464$38.05D0ISee footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses